RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
äŒæ¥ã³ãŒãRXST
äŒç€ŸåRxsight Inc
äžå Žæ¥Jul 30, 2021
æé«çµå¶è²¬ä»»è
ãCEOãKurtz (Ron M)
åŸæ¥å¡æ°498
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jul 30
æ¬ç€Ÿæåšå°100 Columbia Street
éœåžALISO VIEJO
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·92656
é»è©±çªå·19495217822
ãŠã§ããµã€ãhttps://www.rxsight.com/
äŒæ¥ã³ãŒãRXST
äžå Žæ¥Jul 30, 2021
æé«çµå¶è²¬ä»»è
ãCEOãKurtz (Ron M)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã